Molecular Docking of 4-Tert-Buthyl-Bis-(2,6-Thiomorpholin-4-Ylmethyl)-1-Phenol (LQM319) on Fas Receptor (CD95)
Journal of Cancer Therapy
doi 10.4236/jct.2013.41026
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Scientific Research Publishing, Inc.